Browse by author
Lookup NU author(s): Felix Chan, Dr Nichola Lax, Emeritus Professor Doug Turnbull, Professor Mark Cunningham
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Increasingly in the realm of neurological disorders, particularly those involving neurodegeneration, mitochondrial dysfunction is emerging at the core of their pathogenic processes. Most of these diseases still lack effective treatment and are hampered by a shortfall in the development of novel medicines. Clearly new targets that translate well to the clinic are required. Physiological parameters in the form of neuronal network activity are increasingly being used as a therapeutic screening approach in drug development and disorders with mitochondrial dysfunction generally display neuronal network activity disturbance. However research directly linking the disturbances in neuronal network activity with mitochondrial dysfunction is only just starting to emerge. This review will summarize the breadth of knowledge linking neuronal network activity to mitochondrial dysfunction in neurodegenerative diseases and suggest potential avenues for exploration in respect to future drug development.
Author(s): Chan F, Lax NZ, Davies CH, Turnbull DM, Cunningham MO
Publication type: Review
Publication status: Published
Journal: Neuropharmacology
Year: 2016
Volume: 102
Pages: 48-58
Print publication date: 01/03/2016
Online publication date: 28/10/2015
Acceptance date: 24/10/2015
ISSN (print): 0028-3908
ISSN (electronic): 1873-7064
URL: http://dx.doi.org/10.1016/j.neuropharm.2015.10.033
DOI: 10.1016/j.neuropharm.2015.10.033
